상세 보기

Sorafenib with versus without concurrent conventional transarterial chemoembolization (cTACE) in patients with advanced hepatocellular carcinoma (HCC): Results from a multicenter, open-label, randomized, controlled phase III STAH trial

Park, J. -W.;
Kim, Y. J.;
Kim, D. Y.;
Bae, S. H.;
Paik, S. W.;
... Yeon, J. E.;
외 8명

제목: Sorafenib with versus without concurrent conventional transarterial chemoembolization (cTACE) in patients with advanced hepatocellular carcinoma (HCC): Results from a multicenter, open-label, randomized, controlled phase III STAH trial

저자: Park, J. -W.; Kim, Y. J.; Kim, D. Y.; Bae, S. H.; Paik, S. W.; Lee, Y. -J.; Lee, D.; Lee, H. C.; Han, S. Y.; Cheong, J. Y.; Kwon, O. S.; Yeon, J. E.; Kim, B. H.; Hwang, J. -S.

DOI: 10.1016/S0168-8278(18)30222-8

발행일: 2018-04

학회명: International Liver Congress (ILC) 2018

개최지: Paris, FRANCE

개최국가: 네덜란드

학회 개최일: 2018-04-11 ~ 2018-04-15

언어: ENG